LV10265B - Derivatives of pyridine and pyrimidine, their preparation, pharmaceutical composition and treating method - Google Patents

Derivatives of pyridine and pyrimidine, their preparation, pharmaceutical composition and treating method Download PDF

Info

Publication number
LV10265B
LV10265B LVP-93-577A LV930577A LV10265B LV 10265 B LV10265 B LV 10265B LV 930577 A LV930577 A LV 930577A LV 10265 B LV10265 B LV 10265B
Authority
LV
Latvia
Prior art keywords
hydrogen
lower alkyl
halogen
hjih
cyano
Prior art date
Application number
LVP-93-577A
Other languages
English (en)
Latvian (lv)
Other versions
LV10265A (lv
Inventor
Olsson Knut Gunnar
Abramo Aina Lisbeth
Torbjoern Lundstedt Erik
Harry Nordvi Curt
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of LV10265A publication Critical patent/LV10265A/xx
Publication of LV10265B publication Critical patent/LV10265B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
LVP-93-577A 1988-09-28 1993-06-15 Derivatives of pyridine and pyrimidine, their preparation, pharmaceutical composition and treating method LV10265B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8803429A SE8803429D0 (sv) 1988-09-28 1988-09-28 Novel pyridyl- and pyrimidyl derivatives
HU895103A HU203232B (en) 1988-09-28 1989-09-28 Process for producing new pyridyl and pyrimidinyl derivatives

Publications (2)

Publication Number Publication Date
LV10265A LV10265A (lv) 1994-10-20
LV10265B true LV10265B (en) 1995-08-20

Family

ID=26317811

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-577A LV10265B (en) 1988-09-28 1993-06-15 Derivatives of pyridine and pyrimidine, their preparation, pharmaceutical composition and treating method

Country Status (25)

Country Link
US (1) US5034390A (ja)
EP (1) EP0361271B1 (ja)
JP (1) JP2857693B2 (ja)
KR (1) KR930007413B1 (ja)
CN (1) CN1028756C (ja)
AT (1) ATE97665T1 (ja)
AU (1) AU616307B2 (ja)
CA (1) CA1337417C (ja)
DD (1) DD290884A5 (ja)
DE (1) DE68910922T2 (ja)
DK (1) DK171133B1 (ja)
ES (1) ES2060709T3 (ja)
FI (1) FI94629C (ja)
HU (1) HU203232B (ja)
IE (1) IE62790B1 (ja)
IL (1) IL91701A (ja)
LT (1) LT3549B (ja)
LV (1) LV10265B (ja)
NO (1) NO174667C (ja)
NZ (1) NZ230743A (ja)
PH (1) PH27039A (ja)
PT (1) PT91826B (ja)
RU (1) RU2021269C1 (ja)
SE (1) SE8803429D0 (ja)
ZA (1) ZA897404B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219855A (en) * 1988-01-29 1993-06-15 Mitsubishi Kasei Corporation Anxiolytic drug
IE911774A1 (en) * 1990-06-11 1991-12-18 Akzo Nv Pyridinylpiperazine derivatives
US5166148A (en) * 1990-07-09 1992-11-24 The Du Pont Merck Pharmaceutical Company 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
US5270312A (en) * 1990-11-05 1993-12-14 Warner-Lambert Company Substituted piperazines as central nervous system agents
AU681310B2 (en) * 1994-09-30 1997-08-21 Pfizer Inc. 2,7-substituted octahydro-1h-pyrido{1,2-a}pyrazine derivatives
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DE19600934A1 (de) * 1996-01-12 1997-07-17 Basf Ag Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
SE9601708D0 (sv) * 1996-05-06 1996-05-06 Pharmacia Ab Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
PL203140B1 (pl) 1997-10-27 2009-08-31 Neurosearch As Pochodna homopiperazyny, kompozycja farmaceutyczna zawierająca te pochodne i zastosowanie tej pochodnej
US8013156B2 (en) 2003-03-19 2011-09-06 Exelixis, Inc. Tie-2 modulators and methods of use
WO2018148529A1 (en) * 2017-02-10 2018-08-16 Florida A&M University Identification of agents displaying functional activation of dopamine d2 and d4 receptors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
GB966493A (en) * 1961-11-13 1964-08-12 Soc Ind Fab Antibiotiques Sifa Novel n,n-disubstituted piperazine compounds and their preparation
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4339580A (en) * 1979-06-26 1982-07-13 Mitsubishi Chemical Industries, Limited Piperazinylalkoxyindanes and acid addition salts thereof
CH659069A5 (en) * 1983-11-02 1986-12-31 Sandoz Ag 2-Piperazino- or -homopiperazino-quinazoline derivatives, process for their preparation and pharmaceuticals containing them
US4701456A (en) * 1984-09-19 1987-10-20 Warner-Lambert Company Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents
US4892943A (en) * 1985-10-16 1990-01-09 American Home Products Corporation Fused bicyclic imides with psychotropic activity
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
AR242678A1 (es) * 1986-03-05 1993-04-30 Gonzalez Jorge Alberto Mejoras en instrumentos musicales de cuerda de arco.
MX174210B (es) * 1987-02-17 1994-04-28 Pfizer Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
US4748240A (en) * 1987-04-03 1988-05-31 American Home Products Corporation Psychotropic bicyclic imides
HU208690B (en) * 1987-10-26 1993-12-28 Pfizer Process for producing 1-hjeterocyclic sulfonyl-3-(pyrimidinyl piperazinyl)-propane derivatives and pharmaceutical compositions comprising same
JP2712222B2 (ja) * 1988-01-29 1998-02-10 三菱化学株式会社 抗不安薬
US4873331A (en) * 1988-12-09 1989-10-10 American Home Products Corporation Noradamantyl-carboxylic acid piperazinoalkyl esters

Also Published As

Publication number Publication date
NO893853D0 (no) 1989-09-27
JPH02134368A (ja) 1990-05-23
ATE97665T1 (de) 1993-12-15
IL91701A (en) 1993-05-13
IE892994L (en) 1990-03-28
HUT51611A (en) 1990-05-28
PH27039A (en) 1993-02-01
FI894604A0 (fi) 1989-09-28
US5034390A (en) 1991-07-23
CA1337417C (en) 1995-10-24
EP0361271B1 (en) 1993-11-24
FI94629C (fi) 1995-10-10
NZ230743A (en) 1991-08-27
IL91701A0 (en) 1990-06-10
IE62790B1 (en) 1995-03-08
DK477189A (da) 1990-03-29
DD290884A5 (de) 1991-06-13
JP2857693B2 (ja) 1999-02-17
HU203232B (en) 1991-06-28
FI94629B (fi) 1995-06-30
DK171133B1 (da) 1996-06-24
LT3549B (en) 1995-11-27
FI894604A (fi) 1990-03-29
ES2060709T3 (es) 1994-12-01
AU616307B2 (en) 1991-10-24
NO174667B (no) 1994-03-07
ZA897404B (en) 1990-07-25
SE8803429D0 (sv) 1988-09-28
PT91826A (pt) 1990-03-30
NO174667C (no) 1994-06-15
DK477189D0 (da) 1989-09-27
CN1041360A (zh) 1990-04-18
KR930007413B1 (ko) 1993-08-10
LTIP604A (en) 1995-01-31
RU2021269C1 (ru) 1994-10-15
LV10265A (lv) 1994-10-20
DE68910922T2 (de) 1994-03-17
AU4173789A (en) 1990-04-05
CN1028756C (zh) 1995-06-07
DE68910922D1 (de) 1994-01-05
EP0361271A1 (en) 1990-04-04
PT91826B (pt) 1995-05-31
KR900004720A (ko) 1990-04-14
NO893853L (no) 1990-03-29

Similar Documents

Publication Publication Date Title
LV10265B (en) Derivatives of pyridine and pyrimidine, their preparation, pharmaceutical composition and treating method
US5302606A (en) Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
US5656655A (en) Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase
KR101769616B1 (ko) 암 치료에 유용한 화합물
AU658567B2 (en) Styryl-substituted indole and pyridyl compounds
US4723011A (en) Preparation of substituted and disubstituted-pyridine-2,3-dicarboxylate esters
HUP0401748A2 (hu) 2-Amino-4,5-triszubsztituált tiazolilszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0100860A2 (hu) Retinsav utánzó anilidek, eljárás az előállításukra valamint ezeket tartalmazó gyógyászati készítmények
US20120309742A1 (en) Use of metabotropic glutamate receptors
JP2013545771A (ja) Ｈｄｌコレステロール上昇剤としてのオキシム化合物
NZ238701A (en) 2,4- and 2,5-substituted pyridine-n-oxides and pharmaceutical compositions
US5677329A (en) Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
US4465686A (en) 5-(Hydroxy- and/or amino-phenyl)-6-(lower-alkyl)-2-(1H)-pyridinones, their cardiotonic use and preparation
JP2512656B2 (ja) トロポロン誘導体ならびに虚血性疾患を予防および治療するためのその薬剤組成物
CZ282880B6 (cs) Způsob přípravy substituovaných a nesubstituovaných 2,3-pyridinkarboxylátů
Marks et al. Studies of the relationship between chemical structure and porphyria-inducing activity
DE60015844D1 (de) Pyridin- und Piperidinderivate zur Behandlung von neurodegenerativen Erkrankungen
US4018770A (en) N-(2-(pyridinyl)-4-pyrimidinyl)-aminomethylenemalonates and analogs
NO943738D0 (no) Nye perhydroisoindolderivater og deres fremstilling
Ishmetova et al. Synthesis and tuberculostatic activity of amine-substituted 1, 2, 4, 5-tetrazines and pyridazines
US6034086A (en) Trifluoromethylquinolinecarboxylic acid derivative
DK483282A (da) Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf
KR970701177A (ko) 아세트산 아미드 유도체 및 그것의 제조 방법(amide derivatives and process for the preparation thereof)
US4032523A (en) 4-amino (or halo or hydroxy or hydrazino)-2-(pyridinyl)pyrimidines
Katritzky et al. 31. N-oxides and related compounds. Part VII. Per-acid oxidation of some conjugated pyridines